News
AI Target Identification: A novel approach to drive drug R&D in IPF?
Within the realm of lung diseases, developing new drugs to treat Idiopathic Pulmonary Fibrosis (IPF) remains a formidable challenge. Characterized by progressive scarring of
Updates from SMR Meeting: ‘The Innovation Landscape’
Back in July 2022 the SMR (Society for Medicines Research) hosted a conference on ‘Innovative new pharma and biotech partnerships: How is the landscape transforming?’
First drug approval in NASH
When we reviewed the R&D landscape in nonalcoholic steatohepatitis (NASH) in 2018, we highlighted 4 development programs that were in Phase 3 development and all
SMR meeting: The Innovation Landscape
On Tuesday 26 March Darcey Black, Translational Science Director at TherapeutAix, will be co-organising and co-sharing the SMR meeting taking place at Friends House, London.
How rare diseases came to be defined: Rare Disease Day 2024
Today is Rare Disease Day, an international awareness day that takes place annually on 28th February (or 29th on leap years like this one) –
Welcome 2024
With the New Year up and running, we all got together in Aachen for a Board Meeting. In addition to mapping out activities for 2024,
TherapeutAix Roundup: 2023
As 2023 comes to an end we wanted to take the time to reflect upon the year and share what we have been up to.